721 results on '"Lutzke, Lori"'
Search Results
2. Smokeless Tobacco and Cigar and/or Pipe Are Risk Factors for Barrett Esophagus in Male Patients With Gastroesophageal Reflux Disease
3. Screening patients for Barrett esophagus: Why, who, and how
4. Screening and Preventive Strategies in Esophagogastric Cancer
5. Breath Testing for Barrett’s Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device
6. Comparative diagnostic performance of volumetric laser endomicroscopy and confocal laser endomicroscopy in the detection of dysplasia associated with Barrett’s esophagus
7. Clinical and Histologic Determinants of Mortality for Patients With Barrett’s Esophagus–Related T1 Esophageal Adenocarcinoma
8. Prediction of response to endoscopic therapy of Barrett’s dysplasia by using genetic biomarkers
9. Positive correlation between endoscopist radiofrequency ablation volume and response rates in Barrett's esophagus
10. Obstructive Sleep Apnea Is a Risk Factor for Barrett's Esophagus
11. Recurrence of Esophageal Intestinal Metaplasia After Endoscopic Mucosal Resection and Radiofrequency Ablation of Barrett's Esophagus: Results From a US Multicenter Consortium
12. Diagnostic performance of two confocal endomicroscopy systems in detecting Barrett's dysplasia: a pilot study using a novel bioprobe in ex vivo tissue
13. Safety of Prior Endoscopic Mucosal Resection in Patients Receiving Radiofrequency Ablation of Barrett's Esophagus
14. Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma
15. Overutilization of endoscopic surveillance in nondysplastic Barrett's esophagus: a multicenter study
16. Outcomes of T1b esophageal adenocarcinoma patients
17. Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus
18. # 1583 A simplified classification system for lesions in Barrettʼs esophagus: Elevation of lesions and neoplasia risk
19. Endocytoscopy in Esophageal Cancer
20. Endoscopic and Surgical Treatment of Mucosal (T1a) Esophageal Adenocarcinoma in Barrett's Esophagus
21. A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus
22. Utility of Biomarkers in Prediction of Response to Ablative Therapy in Barrett's Esophagus
23. Scissor-type knife improves the safety of endoscopic submucosal dissection (ESD) among endoscopists without experience in ESD: a randomized ex vivo study
24. Rodent Endosonography to Monitor Esophageal Cancer
25. Long-Term Survival Following Endoscopic and Surgical Treatment of High-Grade Dysplasia in Barrett’s Esophagus
26. Factors Associated With Increased Survival After Photodynamic Therapy for Cholangiocarcinoma
27. Endoscopic therapy in patients with Barrett's esophagus and portal hypertension
28. Predictors of stricture formation after photodynamic therapy for high-grade dysplasia in Barrett's esophagus
29. Utility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma
30. Contribution of intraoperative enteroscopy in the management of obscure gastrointestinal bleeding
31. Frozen Section Analysis of Esophageal Endoscopic Mucosal Resection Specimens in the Real-Time Management of Barrett’s Esophagus
32. The Development of a Fluorescence in Situ Hybridization Assay for the Detection of Dysplasia and Adenocarcinoma in Barrett's Esophagus
33. Synergistic effects of photodynamic therapy with HPPH and gemcitabine in pancreatic cancer cell lines
34. HIATAL HERNIA AND THE RESPONSE TO INITIAL CIRCUMFERENTIAL RADIOFREQUENCY ABLATION IN LONG SEGMENT BARRETTʼS ESOPHAGUS: C108.05
35. Depth of Submucosal Invasion Does Not Predict Lymph Node Metastasis and Survival of Patients With Esophageal Carcinoma
36. Correlation of Histology With Biomarker Status After Photodynamic Therapy in Barrett Esophagus
37. Significance of Neoplastic Involvement of Margins Obtained by Endoscopic Mucosal Resection in Barrettʼs Esophagus
38. Combined Endoscopic Mucosal Resection and Photodynamic Therapy Versus Esophagectomy for Management of Early Adenocarcinoma in Barrett’s Esophagus
39. The Effect of Selective Cyclooxygenase-2 Inhibition in Barrettʼs Esophagus Epithelium: An In Vitro Study
40. Tu1950 CLUTCH CUTTER KNIFE IMPROVES THE SAFETY OF ENDOSCOPIC SUBMUCOSAL DISSECTION OVER A CONVENTIONAL KNIFE AMONG NOVICES
41. Sa1153 – Non-Invasive Screening for Barrett's Esophagus Using an Electronic Nose
42. Mo2053 – Pre-Procedural Assessment of the Fasting State by Exhaled Volatile Organic Compounds Using an Electronic Nose
43. Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study
44. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus
45. Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma
46. Combined endoscopic mucosal resection and photodynamic therapy for esophageal neoplasia within Barrett's esophagus
47. Persistent genetic abnormalities in Barrett's esophagus after photodynamic therapy
48. Endoscopic mucosal resection
49. FA02.06: VOLUMETRIC LASER ENDOMICROSCOPY GLAND QUANTIFICATION CAN GUIDE EN-BLOC RESECTION IN DYSPLASTIC BARRETT’S ESOPHAGUS
50. Sa1919 CLUTCH CUTTER KNIFE IMPROVES THE SAFETY OF ENDOSCOPIC SUBMUCOSAL DISSECTION AMONG NOVICES
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.